Osteoporosis affects millions: could modified cells rebuild their bones?
TL;DR - A small clinical trial suggests that modified, bone-seeking marrow cells might help regenerate bone in people with osteoporosis. The limited information provided does not establish the treatment’s efficacy, safety, or durability.
- The experimental cells are designed or modified to target bone tissue.
- The approach aims to rebuild bone rather than only slow bone loss.
- Findings come from a small trial and should be considered preliminary.
- Further studies are needed to assess clinical benefit and risks.